Neuro-urologyDifferential Effects of the Antimuscarinic Agents Darifenacin (cas 133099-04-4) and Oxybutynin ER on Memory in Older Subjects
-
Add time:09/07/2019 Source:sciencedirect.com
ObjectivesTo investigate the effects of Darifenacin (cas 133099-04-4) controlled-release (CR) and oxybutynin extended-release (ER) on cognitive function (particularly memory) in older subjects.
We also recommend Trading Suppliers and Manufacturers of Darifenacin (cas 133099-04-4). Pls Click Website Link as below: cas 133099-04-4 suppliers
Prev:Adult Urology: Voiding DysfunctionINCREASED WARNING TIME WITH Darifenacin (cas 133099-04-4): A NEW CONCEPT IN THE MANAGEMENT OF URINARY URGENCY
Next:In vivo demonstration of M3 muscarinic receptor subtype selectivity of Darifenacin (cas 133099-04-4) in mice) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ReviewDarifenacin (cas 133099-04-4), an M3 Selective Receptor Antagonist, is an Effective and Well-Tolerated Once-Daily Treatment for Overactive Bladder09/25/2019
- Female Urology—IncontinenceComparison of Darifenacin (cas 133099-04-4) and Oxybutynin in Patients with Overactive Bladder: Assessment of Ambulatory Urodynamics and Impact on Salivary Flow09/24/2019
- Neuro-urologyEffects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin (cas 133099-04-4) on Bladder Afferent Activity of the Rat Pelvic Nerve09/10/2019
- Female Urology—IncontinenceTreatment of Overactive Bladder in the Older Patient: Pooled Analysis of Three Phase III Studies of Darifenacin (cas 133099-04-4), an M3 Selective Receptor Antagonist09/09/2019
- In vivo demonstration of M3 muscarinic receptor subtype selectivity of Darifenacin (cas 133099-04-4) in mice09/08/2019
- Adult Urology: Voiding DysfunctionINCREASED WARNING TIME WITH Darifenacin (cas 133099-04-4): A NEW CONCEPT IN THE MANAGEMENT OF URINARY URGENCY09/06/2019
- Adult Urology: Voiding DysfunctionASSESSMENT OF COGNITIVE FUNCTION OF THE ELDERLY POPULATION: EFFECTS OF Darifenacin (cas 133099-04-4)09/05/2019
- Darifenacin (cas 133099-04-4)09/04/2019
- Validated liquid chromatographic–fluorescence method for the quantitation of Darifenacin (cas 133099-04-4) in mice plasma and its application to a pharmacokinetic study09/03/2019